Annals of Hepatology (Sep 2021)

O-10 PRIMARY BILIARY CHOLANGITIS PATIENTS DIAGNOSED BY DIFFERENT COMBINATIONS OF THE DIAGNOSTIC CRITERIA PRESENT CLINICAL AND LABORATORY PECULIARITIES

  • Guilherme G.L. Cançado,
  • Eduardo L.R. Cançado,
  • Maria L.G. Ferraz,
  • Cristiane A. Villela-Nogueira,
  • Debora R.B. Terrabuio,
  • Michelle H. Braga,
  • Mateus J. Nardelli,
  • Luciana C. Faria,
  • Nathalia M.F. GOMES,
  • ELZE M.G. Oliveira,
  • Vivian Rotman,
  • Maria Beatriz Oliveira,
  • Simone M.C.F. Cunha,
  • Daniel F. Mazo,
  • Liliana S.C. Mendes,
  • Claudia A.P. Ivantes,
  • Valéria Faborges,
  • Fabio H.L. Pace,
  • Mario G. Pessoa,
  • Izabelle V. Signorelli,
  • Gabriela P. Coral,
  • Paulo L. Bittencourt,
  • Cynthia Levy,
  • Cláudia A. Couto,
  • Members of the Brazilian Cholestasis Study Group Consortium

Journal volume & issue
Vol. 24
p. 100497

Abstract

Read online

Introduction: Primary biliary cholangitis (PBC) diagnosis is based on international criteria, which requires two of the following: (i) elevated alkaline phosphatase (AP), (ii) anti-mitochondrial antibody (AMA) and (iii) liver biopsy (BX) suggestive of PBC. It is still unclear if patients diagnosed by different criteria combinations present peculiarities, especially in highly-admixed populations. Objectives: To investigate if patients diagnosed with PBC by different combinations of validated criteria present clinical or laboratory particularities. Methods: The Brazilian Cholestasis Study Group database was reviewed to compare clinical, biochemical and histological characteristics of PBC between four groups diagnosed by: (1) AP ≥2x upper limit of normality (ULN) + presence of AMA, (2) AP ≥2x ULN + BX suggestive of PBC, (3) presence of AMA + BX suggestive of PBC and (4) all criteria. Results: 482 patients with PBC were included (Table 1). Group-1 presented with higher levels of IgG, lower frequency of arterial hypertension (AH) and lower response to ursodeoxycholic acid (UDCA), while Group-2 had lower: age at diagnosis and HDL-C levels. Group-3 had higher: age at diagnosis, frequency of neoplasms, AH and response to UDCA; and lower: frequency of pruritus and jaundice, levels of aminotransferases, GGT and bilirubin, advanced liver disease and esophageal varices. Group-4 showed higher frequency of symptoms at presentation, especially pruritus. Conclusion: PBC patients diagnosed by different combinations of established criteria may present singular features that can possibly impact in disease presentation and progression.